LYSVULPEN, peroralinė suspensija
LYSVULPEN, peroralinė suspensija
Authorised
- Rabies virus, strain SAD Bern, Live
Product identification
Medicine name:
LYSVULPEN, peroralinė suspensija
Active substance:
- Rabies virus, strain SAD Bern, Live
Target species:
-
Fox
-
Raccoon dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Rabies virus, strain SAD Bern, Live18000000.00/50% tissue culture infectious dose1.00Dose
Pharmaceutical form:
-
Oral suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07BD
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Package description:
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Lithuanian (PDF)
Published on: 13/11/2024